BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9795238)

  • 1. Structural organization of the human TOP2A and TOP2B genes.
    Lang AJ; Mirski SE; Cummings HJ; Yu Q; Gerlach JH; Cole SP
    Gene; 1998 Oct; 221(2):255-66. PubMed ID: 9795238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A truncated cytoplasmic topoisomerase IIalpha in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34.
    Mirski SE; Sparks KE; Yu Q; Lang AJ; Jain N; Campling BG; Cole SP
    Int J Cancer; 2000 Feb; 85(4):534-9. PubMed ID: 10699927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and characterization of the human topoisomerase IIalpha and IIbeta genes: evidence for isoform evolution through gene duplication.
    Sng JH; Heaton VJ; Bell M; Maini P; Austin CA; Fisher LM
    Biochim Biophys Acta; 1999 Mar; 1444(3):395-406. PubMed ID: 10095062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants.
    Sapetto-Rebow B; McLoughlin SC; O'Shea LC; O'Leary O; Willer JR; Alvarez Y; Collery R; O'Sullivan J; Van Eeden F; Hensey C; Kennedy BN
    BMC Dev Biol; 2011 Nov; 11():71. PubMed ID: 22111588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying the Mechanism of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα and IIβ.
    Keck JM; Conner JD; Wilson JT; Jiang X; Lisic EC; Deweese JE
    Chem Res Toxicol; 2019 Oct; 32(10):2135-2143. PubMed ID: 31512855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms.
    Deng S; Yan T; Jendrny C; Nemecek A; Vincetic M; Gödtel-Armbrust U; Wojnowski L
    BMC Cancer; 2014 Nov; 14():842. PubMed ID: 25406834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
    Nebral K; Schmidt HH; Haas OA; Strehl S
    Clin Cancer Res; 2005 Sep; 11(18):6489-94. PubMed ID: 16166424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two differentially spliced forms of topoisomerase IIalpha and beta mRNAs are conserved between birds and humans.
    Petruti-Mot AS; Earnshaw WC
    Gene; 2000 Nov; 258(1-2):183-92. PubMed ID: 11111056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
    Harker WG; Slade DL; Parr RL; Holguin MH
    Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
    Shapiro AB; Austin CA
    Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.
    Song JH; Kweon SH; Kim HJ; Lee TH; Min WS; Kim HJ; Kim YK; Hwang SY; Kim TS
    Br J Cancer; 2012 Jun; 107(1):108-15. PubMed ID: 22627319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer.
    Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J
    Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary History of TOPIIA Topoisomerases in Animals.
    Moreira F; Arenas M; Videira A; Pereira F
    J Mol Evol; 2022 Apr; 90(2):149-165. PubMed ID: 35165762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon.
    Harkin LF; Gerrelli D; Gold Diaz DC; Santos C; Alzu'bi A; Austin CA; Clowry GJ
    J Anat; 2016 Mar; 228(3):452-63. PubMed ID: 26612825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
    Menendez JA; Vellon L; Lupu R
    Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
    Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
    Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells.
    Belluti S; Basile V; Benatti P; Ferrari E; Marverti G; Imbriano C
    Cell Death Dis; 2013 Aug; 4(8):e756. PubMed ID: 23928695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
    Yu Q; Mirski SE; Sparks KE; Cole SP
    Biochemistry; 1997 May; 36(19):5868-77. PubMed ID: 9153428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase 2β and DNA topology during B cell development.
    Papapietro O; Nejentsev S
    Front Immunol; 2022; 13():982870. PubMed ID: 36045673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.